Senior insider sale
SVP and General Counsel at ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$374.1K
14.89K shares
What this filing means
MATSUDA MASARU plans to sell 14.89K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $374.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/8/2026ACC: 0001628280-26-060930
Officer· SVP and General Counsel
Since Jan 2022
14.89K
Shares to sell
$374.1K
Approx. market value
13.66K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months5
Restricted Stock Vesting
NA
8/1/2025
2.08KRestricted Stock Vesting
NA
5/27/2025
6.47KRestricted Stock Vesting
NA
2/27/2025
200.00Restricted Stock Vesting
NA
11/1/2024
840.00Restricted Stock Vesting
NA
5/1/2024
4.07KTotal acquired13.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/1/2025 | Restricted Stock Vesting NA | 2.08K | — |
5/27/2025 | Restricted Stock Vesting NA | 6.47K | — |
2/27/2025 | Restricted Stock Vesting NA | 200.00 | — |
11/1/2024 | Restricted Stock Vesting NA | 840.00 | — |
5/1/2024 | Restricted Stock Vesting NA | 4.07K | — |
| Total | 13.66K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.23K
Market value
$32.1K
8/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
13.66K
Market value
$341.9K
9/8/2026
Total
Units
14.89K
Value
$374.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/3/2026 | 1.23K | $32.1K | — | Completed |
| Planned — Approximate Date | ||||
9/8/2026 | 13.66K | $341.9K | NASDAQ | Planned |
| Total | 14.89K | $374.1K | ||